Compounds and methods for treating prostate cancer are provided. The inventive compounds include polypeptides containing at least a portion of a prostate tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of prostate cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.

Os compostos e os métodos para tratar o cancer do prostate são fornecidos. Os compostos inventive incluem os polypeptides que contêm ao menos uma parcela de uma proteína do tumor do prostate. As vacinas e as composições pharmaceutical para o immunotherapy do cancer do prostate que compreende tais polypeptides, ou moléculas do DNA que codificam tais polypeptides, são fornecidas também, junto com moléculas do DNA preparando os polypeptides inventive.